Chromatographic Chiral Separations on Immobilised Proteins: Does High-Performance Liquid Chromatography Mirror Nature?

  • I. W. Wainer
Part of the Chromatographic Society Symposium Series book series (CSSS)


A commercially available high-performance liquid chromatography (HPLC) chiral stationary phase (CSP) based upon immobilised bovine serum abumin, the BSA-CSP, has been used to investigate the protein binding of enantiomeric solutes. The changes in the chromatographic retention which resulted from the addition of mobile phase modifiers were compared with parallel in vitro protein binding studies. The results of these studies indicate that the commercially available BSA-CSP can be used to investigate the binding interactions between a series of solutes and the protein. The use of mobile phase modifiers has demonstrated a direct relationship between in vitro protein binding and chromatographic retention. In addition, the use of enantiomeric solutes has shown that the BSACSP can be used to probe the number and relative affinities of various binding sites on the protein.


Human Serum Albumin Lauric Acid Chiral Stationary Phase Chromatographic Retention Bovine Serum Albumin Molecule 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D. A. Brent, J. J. Sabatka, D. J. Minick and D. W. Henry, J. Med. Chem, 26: 1014–1020 (1983).PubMedCrossRefGoogle Scholar
  2. 2.
    N. El Tayar, H. Van de Waterbeemd and B. Testa, J. Chromatogr, 320: 305–312 (1985).CrossRefGoogle Scholar
  3. 3.
    T. Braumann, J. Chromatogr., 373: 191–225 (1986).PubMedCrossRefGoogle Scholar
  4. 4.
    T. L. Hafkensheid and E. Tomlinson, J. Chromatogr., 292: 305–317 (1984).CrossRefGoogle Scholar
  5. 5.
    W. E. Hammers, G. J. Meurs and C. L. de Ligny, J. Chromatogr, 247: 1–13 (1982).CrossRefGoogle Scholar
  6. 6.
    J. Ganansa, L. Bianchetti and J. P. Thenot, J. Chromatogr., 421: 83–90 (1987).CrossRefGoogle Scholar
  7. 7.
    I. Marie, C. Pettersson and T. Arvidsson, J. Chromatogr., 456: 323–326 (1988).Google Scholar
  8. 8.
    S. Allenmark, B. Bomgren and H. Boren, J. Chromatogr., 264: 63–68 (1983).CrossRefGoogle Scholar
  9. 9.
    J. Hërmansson, J. Chromatogr., 269: 71–80 (1983).CrossRefGoogle Scholar
  10. 10.
    R. C. Jewell, K. L. R Brouwer and P. J. McNamara, J. Chromatogr., 487: 257–264 (1989).PubMedCrossRefGoogle Scholar
  11. 11.
    N. Lammers,H. de Bree, C. P. Groen, H. M. Ruijten and B. J. de Jong, in: “Bioanalysis of Drugs and Metabolites, Especially Anti-inflammatory and Cardiovascular”, E. Reid, J. D. Robinson and I. D. Wilson, eds., Plenum Press, New York, pp 301–303 (1988).Google Scholar
  12. 12.
    W. E. Muller, in: “Drug Stereochemistry: Analytical Methods and Pharmacology”, I. W. Wainer and D. E. Drayer, eds., Marcel Dekker, New York, pp 227–244 (1988).Google Scholar
  13. 13.
    W. E. Muller and U. Wollert, Pharmacology, 19: 59–67 (1979).PubMedCrossRefGoogle Scholar
  14. 14.
    J. P. Tillement, G. Houin, R Zini, S. Urien, E. Albengres, J. Barre, J. Lacomte, P. D’Athis and B. Sebille, Adv. Drug Res, 13: 59–94 (1984).Google Scholar
  15. 15.
    I. Sjoholm, in: “Drug Protein Binding”, M. M. Ridenberg and S. Erill, eds., Prager Publishers, Philadelphia, pp 158–178 (1988).Google Scholar
  16. 16.
    U. Kragh-Hansen, Pharmacol. Rev., 33: 17–53 (1981).PubMedGoogle Scholar
  17. 17.
    K. J. Fehske, W. E. Muller and U. Wollert, Biochem. PharmacoL, 30: 687–692 (1981).PubMedCrossRefGoogle Scholar
  18. 18.
    E. M. Sellers and J. Koch-Weser, Ann. N. Y. AcacL Sci., 179: 213–225 (1971).CrossRefGoogle Scholar
  19. 19.
    N. A. Brown, E. Jahnchen, W. E. Muller and U. Wollert, Mol. PharmacoL, 13: 70–79 (1977).PubMedGoogle Scholar
  20. 20.
    M. Otagiri, J. S. Fleitman and J. H. Perrin, J. Pharm. Pharmacol., 32: 478 (1980).PubMedCrossRefGoogle Scholar
  21. 21.
    W. E. Muller and U. Wollert, Mot. PharmacoL, 11: 52–60 (1975).Google Scholar
  22. 22.
    T. Alebic-Kolbah, F. Kajfez, S. Rendic, V. Sunic, A. Konowal and G. Snatzke, Biochem. PhannacoL, 28: 2457–2464 (1979).CrossRefGoogle Scholar
  23. 23.
    G. Grafton, E. Decorte, F. Moimas, C. Angeli and V. Sunjic, Il Farmaco Ed. Sci, 40: 209215 (1985).Google Scholar
  24. 24.
    A. Konowal, G. Snatzke, T. Alebic-Kolbah, F. Kajfez, S. Rendic and V. Sunjic, Biochem. PharmacoL, 28: 3109–3113 (1979).PubMedCrossRefGoogle Scholar
  25. 25.
    I. W. Wainer and Y.-Q. Chu, J. Chromatogr., 455: 316–322 (1988).PubMedCrossRefGoogle Scholar
  26. 26.
    A. J. Muller and P. W. Carr, J. Chromatogr., 284: 33–51 (1984).CrossRefGoogle Scholar
  27. 27.
    A. J. Muller and P. W. Can, J. Chromatogr., 357: 11–32 (1986).CrossRefGoogle Scholar
  28. 28.
    G. Blaschke, Angew. Chem. Int. Ed. Eng., 19:13 (1980).CrossRefGoogle Scholar
  29. 29.
    S. Allenmark, B. Bomgren and H. Boren, J. Chromatogr., 316: 617–624 (1984)CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • I. W. Wainer
    • 1
  1. 1.St. Jude Children’s Research HospitalMemphisUSA

Personalised recommendations